Impaired upper respiratory tract barrier function during postnatal development predisposes to invasive pneumococcal

Kristen L Lokken-Toyli1, Surya D Aggarwal1, Gavyn Chern Wei Bee1

  • 1Department of Microbiology, New York University School of Medicine, New York, New York, United States of America.

Plos Pathogens
|May 8, 2024
PubMed

Insights

Infant mice show increased susceptibility to Streptococcus pneumoniae (Spn) infections due to impaired upper respiratory tract (URT) barrier function. This vulnerability, characterized by delayed mucociliary clearance and altered tight junction gene expression, facilitates bacterial spread and bloodstream dissemination in early life.

Area of Science:

  • Immunology
  • Microbiology
  • Developmental Biology

Background:

  • Infants are vulnerable to invasive respiratory and gastrointestinal infections.
  • Understanding age-dependent mechanisms of bacterial spread is crucial for pediatric health.

Purpose of the Study:

  • To investigate the mechanisms underlying increased susceptibility to Streptococcus pneumoniae (Spn) in infant mice.
  • To elucidate age-dependent bacterial dissemination from the upper respiratory tract (URT) mucosa.

Main Methods:

  • Developed an infant mouse model for Spn infection.
  • Utilized molecular barcoding to track bacterial dissemination.
  • Performed transcriptional profiling of the URT epithelium.
  • Assessed URT barrier permeability and mucociliary clearance.

Main Results:

  • Infant mice exhibited decreased survival and increased Spn bacteremia compared to adults.
  • Bacterial dissemination was not linked to immune cell infiltration or specific inflammatory pathways.
  • Infant URT epithelium failed to upregulate tight junction genes, indicating impaired barrier function.
  • Increased URT permeability and delayed mucociliary clearance were observed in infant mice.

Conclusions:

  • A critical window of vulnerability exists during early postnatal development.
  • Altered mucosal barrier function, specifically impaired tight junctions and delayed clearance, facilitates bacterial dissemination in infants.
  • Findings highlight the importance of mucosal barrier maturation in preventing invasive infections.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
223
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
203
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
260
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
303
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.8K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
276